GORE VIABAHN® Endoprosthesis
GORE VIABAHN® Endoprosthesis is a medical device with 7 clinical trials. Historical success rate of 85.7%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
85.7%
6 of 7 finished
14.3%
1 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study (JPS 16-03)
In-Stent Restenosis Post-Approval Study
Treatment of Patients With Traumatic or Iatrogenic Vessel Injuries
Evaluation of the GORE® VIABAHN® Endoprosthesis for the Treatment of Popliteal Artery Aneurysm (PAA)
Evaluation of GORE® VIABAHN® Endoprosthesis for Popliteal Artery Aneurysm
Clinical Trials (7)
GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study (JPS 16-03)
In-Stent Restenosis Post-Approval Study
Treatment of Patients With Traumatic or Iatrogenic Vessel Injuries
Evaluation of the GORE® VIABAHN® Endoprosthesis for the Treatment of Popliteal Artery Aneurysm (PAA)
Evaluation of GORE® VIABAHN® Endoprosthesis for Popliteal Artery Aneurysm
GORE VIABAHN® Versus Plain Old Balloon Angioplasty (POBA) for Superficial Femoral Artery (SFA) In-Stent Restenosis
GORE VIABAHN ENDOPROSTHESIS Peripheral Vascular Disease Study
All 7 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 7